Results 31 to 40 of about 1,628,367 (268)

Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease. [PDF]

open access: yesCytokine, 2020
Interleukin (IL)-38 belongs to the IL-1 family and is part of the IL-36 subfamily due to its binding to the IL-36 Receptor (IL-1R6). In the current study, we assessed the anti-inflammatory properties of IL-38 in murine models of arthritis and systemic inflammation.
Dennis M. de Graaf   +12 more
semanticscholar   +7 more sources

Interleukin-38 in colorectal cancer: a potential role in precision medicine [PDF]

open access: yesCancer Immunology, Immunotherapy, 2019
Colorectal cancer (CRC) is a leading cause of cancer-related death, partly due to a lack of reliable biomarkers for early diagnosis. To improve the outcome of CRC, it is critical to provide diagnosis at an early stage using promising sensitive/specific marker(s).
Feier Chen   +5 more
semanticscholar   +4 more sources

Interleukin-38 in Health and Disease. [PDF]

open access: yesCytokine, 2022
Contains fulltext : 252005.pdf (Publisher’s version ) (Open Access)
Dennis M. de Graaf   +3 more
semanticscholar   +4 more sources

Imbalance between serum interleukin-36 and interleukin-38 is associated with metabolic syndrome in psoriasis vulgaris

open access: diamondJournal of the Egyptian Women’s Dermatologic Society, 2023
Background In psoriasis, interleukin (IL)-36 is considered a pathogenic driver, whereas IL-38 was downregulated. Little is known about their role in metabolic syndrome (Ms) in psoriasis.
Marwa Ahmed Amer   +6 more
openalex   +3 more sources

IL-38 as a Novel Biomarker in Multiple Myeloma Patients: A Prospective Clinical Evaluation [PDF]

open access: yesCancer Management and Research
Hailan Shen, Ping Zhao, Ju Cao Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of ChinaCorrespondence: Ju Cao, Department of Laboratory Medicine, The First Affiliated Hospital
Shen H, Zhao P, Cao J
doaj   +4 more sources

Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity [PDF]

open access: bronzeJournal of Cosmetic Dermatology, 2021
Vitiligo is an acquired cutaneous depigmenting disease caused by a T helper (Th) 1–cytotoxic T cells driven autoimmune attack against melanocytes, in which Th17 is also involved.
Radwa El‐Sayed Mahmoud Marie   +3 more
openalex   +2 more sources

Evaluating the Role of Interleukin-36 and Interleukin-38 in Acne Vulgaris Patients [PDF]

open access: bronzeBenha Journal of Applied Sciences, 2020
Interleukin (IL)- 36 and (IL)- 38 cytokines are individuals from the IL-1 family, which incorporate favorable to infammatory factors and over late years, much has been educated on their significant capacities in the guideline of safe reaction and, particularly, on their function in numerous infammatory skin sicknesses.
Fatma Mohamed Elesawy   +3 more
openalex   +2 more sources

Interleukin 38 Protects Against Lethal Sepsis [PDF]

open access: yesThe Journal of Infectious Diseases, 2018
Interleukin 38 (IL-38) is the most recently characterized cytokine of the interleukin 1 family. However, its role in sepsis remains unknown.Circulating IL-38 levels were measured in 2 cohorts of adult and pediatric patients with sepsis. Using 2 murine models of lipopolysaccharide (LPS)-induced endotoxemia and cecal ligation and puncture (CLP)-induced ...
Fang Xu   +6 more
semanticscholar   +4 more sources

Interleukin-38 promoter variants and risk of COVID-19 among Iraqis [PDF]

open access: yesImmunobiology, 2022
Coronavirus disease-19 (COVID-19) has recently emerged as a respiratory infection with a significant impact on health and society. The pathogenesis is primarily attributed to a dysregulation of cytokines, especially those with pro-inflammatory and anti-inflammatory effects. Interleukin-38 (IL-38) is a recently identified anti-inflammatory cytokine with
Al-Karaawi, Ibtihal A.   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy